Allopurinol therapy in gout patients does not associate with beneficial cardiovascular outcomes: A population-based matched-cohort study

Agriculture & Biology

• gout 99%
• allopurinol 98%
• cohort studies 93%
• therapeutics 52%
• cardiovascular diseases 32%
• confidence interval 20%
• hyperuricemia 16%
• atrial fibrillation 15%
• comorbidity 15%
• acute kidney injury 15%
• uremia 14%
• renal calculi 14%
• stomach ulcers 13%
• alcohol drinking 12%
• relative risk 12%
• diabetes mellitus 12%
• kidney diseases 12%
• hepatitis 12%
• hyperlipidemia 11%
• body mass index 11%
• atherosclerosis 10%
• uric acid 10%
• hypertension 10%
• blood pressure 9%
• risk factors 9%
• experimental design 7%
• blood vessels 7%
• dates (fruit) 7%
• oxidative stress 7%
• gender 5%
• methodology 2%

Medicine & Life Sciences

• Allopurinol 85%
• Gout 81%
• Cohort Studies 46%
• Population 26%
• Cardiovascular Diseases 21%
• Uric Acid 19%
• Uricosuric Agents 17%
• Nephrolithiasis 12%
• Hyperuricemia 12%
• Confidence Intervals 11%
• Uremia 11%
• Therapeutics 11%
• Stomach Ulcer 10%
• Hyperlipidemias 9%
• Acute Kidney Injury 9%
• Hepatitis 9%
• Chronic Renal Insufficiency 8%
• Alcohol Drinking 8%
• Proportional Hazards Models 8%
• Atrial Fibrillation 8%
• Atherosclerosis 7%
• Diabetes Mellitus 7%
• Comorbidity 7%
• Oxidative Stress 7%
• Smoking 7%
• Body Mass Index 6%
• Retrospective Studies 6%
• Hypertension 6%
• Blood Pressure 6%
• Blood Vessels 5%

Chemical Compounds

• Allopurinol 100%
• Uricosuric Agent 19%
• Blood Pressure 12%
• Uric Acid 10%
• Oxidative Stress 9%
• Time 3%